Key insights
- USP <71> test method method is used to confirm the absence of any viable microorganisms in sterile products
- It is primarily applicable to sterile pharmaceuticals, biologics and certain medical devices
- Two validated approaches are used in this test method : Membrane filtration and Direct transfer method
- The test procedure involves incubating samples for 14 days period in specific culture media to detect microbial growth
- USP <71> is a qualitative test method, provides results as a pass or fail based on microbial growth
Summary
USP <71> sterility testing is a U.S Pharmacopeial method that confirms the absence of viable microorganisms in sterile pharmaceutical products, biologics and medical devices. It provides a qualitative pass/fail criteria. The standard has two methods: Membrane Filtration and Direct Inoculation (Direct Transfer)
What is USP <71> sterility testing?
USP <71> test method, also known as sterility testing, is used to determine whether sterile products are free of any viable microorganisms. The USP <71> test method is defined under United States Pharmacopeia guidelines and is widely referred in global regulatory frameworks for sterile product claims. It provides a qualitative pass/fail assessment to confirm the absence of microorganisms
Why is USP <71> important?
The USP <71> test method plays an important role in ensuring consumer safety and regulatory compliance,
USP <71>:
- Ensures sterile products are free from viable microorganisms
- Supports regulatory approval for injectables and implantable products
- Validates aseptic manufacturing processes
- Reduces risk of infection in clinical use
- Ensures compliance with global pharmacopeial standards
Products covered under USP <71>
It applies to pharmaceutical and medical sectors:
- Pharmaceuticals – Parenteral products, ophthalmic preparation, inhalation solutions etc
- Medical devices – Implantable devices, sterile surgical instruments, Catheters, syringes etc
- Biologics and radiopharmaceuticals – Vaccines, blood-derived products, radiopharmaceuticals with short shelf life.
Principle of USP <71> sterility testing
USP <71> test method is based on exposing the f test sample in nutrient-rich culture media followed by incubation period under controlled environmental conditions to detect microbial growth.
Post incubation, if microorganisms are visually detectable, then the product is said to fail the test. Absence of growth indicates a pass result.
Why sterility testing does not prove sterility
Despite its important role, USP <71> has its own limitations
- A negative result (Pass) only indicates that no microorganisms were detected in the tested samples, but does not indicate absolute sterility
- Sterility testing is done on a limited sample size. Contamination present in untested units can still be undetected.
- Sterility testing must be supported by robust aseptic controls and environmental monitoring.
Test media used in USP <71> test method
Common media used in USP <71> test method include:
- Fluid Thioglycollate Medium(FTM) – for anaerobic and aerobic bacteria
- Soyabean-Casein Digest Medium (SCDM) – for fungi and aerobic bacteria
Test organisms used for USP <71> test method
Aerobic bacteria – Staphylococcus aureus, Bacillus subtilis, Pseudomonas aeruginosa
Anaerobic bacteria – Clostridium sporogenes
Fungi – Candida albicans, Aspergillus niger
USP <71> test procedure
Membrane filtration method
This method is used for filterable products such as aqueous, oily and alcoholic formulations.
Procedure –
- The membrane filter to be used is sterilized and apparatus is setup under aseptic conditions
- The product is passed through the filter
- After filtration, the membrane is incubated for specified period of time in suitable growth medium
- After incubation, the results are observed and recorded
Direct transfer sterility testing
This method is used for products that cannot be filtered, like ointments, suspensions, bulk solids or medical devices
Procedure –
- A specified quantity of product is directly added to the media
- If the product contains antimicrobial properties, neutralizers are added
- The inoculated culture is then incubated for specified period of time
- After incubation, the growth is observed
Also check – USP 71 vs USP 61: Sterility Testing vs Microbial Enumeration
Membrane filtration vs direct transfer: which method should be used?
Choosing the right method depends on several factors
| Parameter | Membrane filtration | Direct transfer method |
| Product type | Filterable products – aqueous, oily and alcoholic formulations. | Non-filterable products – ointments, suspensions, bulk solids or medical devices |
| Preference | Often preferred | Preferred when products are non-filterable |
Growth promotion test
The growth promotion test used in USP <71> verifies that the culture media supports the growth of test microorganisms. This step plays an important role as it confirms the performance and sensitivity of the test media to ensure reliable detection and enumeration of test microorganisms.
Method suitability test
The suitability test is used to confirm that the product does not inhibit microbial growth or interfere with microbial detection when undergoes testing. The presence of antimicrobial or preservative agents usually suppresses microbial recovery and results in false-negatives. This assessment ensures that the sterility method is reliable.
Common reasons why USP <71> test fails
Failure of USP <71> can be due to several reasons including:
- Ineffective sterilization process validation
- Residual antimicrobial activity in sample
- incorrect incubation conditions
- Laboratory contamination during handling
Interpretation of results
USP <71> test method provides a qualitative result
- Pass – No visible microbial growth observed after specified incubation period
- Fail – Any visible microbial growth detected
USP <71> test method vs other tests
| Parameter | USP <71> | USP <85> | USP <61> |
| Purpose | To confirm absence of viable microorganisms in finished sterile products | To detect and quantify bacterial endotoxins in pharmaceutical products | To quantitatively determine the microbial counts in measuring Total Aerobic Bacteria Count (TAMC) and Total Yeast and Mold Count (TYMC) |
| Regulatory acceptance | Accepted by FDA, EMA and other global regulators | Accepted by FDA, EMA and other global regulators | Accepted by FDA, EMA and other global regulators |
| Scope of products | Pharmaceuticals, biologics and medical devices | Injectables, biologics and endotoxin-sensitive medical devices | Non-sterile products such as pharmaceuticals (oral solids/liquids, creams, ointments), cosmetics and personal care products |
| Test outcome | Qualitative (Pass or fail) | Qualitative (gel-clot) or quantitative (turbidimetric/chromogenic) | Quantitative – Reported as colony-forming units (CFU) per gram or mL and compared to acceptance limits in USP <1111> |
Also read
Regulatory significance of USP <71> test method
Sterility testing plays a critical role in ensuring the safety of patients. Contaminated products cause infections and complications that could be severely dangerous to patients. USP <71> is widely recognized by global regulators. The US FDA, EMA recognize and accept USP <71> as a standard sterility test for testing sterile pharmaceuticals, biologics, and medical devices marketed in the United States and Europe. USP <71> is also an important part of Good Manufacturing Practice (GMP). It supports decision making in batch releases, process validation and medical fill qualification. In modern sterility testing pharma industries, it serves as a final confirmation step within broader sterility assurance tests.
Need USP <71> sterility testing services?
At MIS, Our expert microbiology team provides comprehensive microbiology testing services. By performing rigorous testing in accordance with USP <71> standard protocols, we provide reliable and reproducible results that support regulatory compliance and validate product quality.
Got any questions? Contact our experts today to get more information on USP <71>
FAQs
1. Does USP <71> detect viruses, endotoxins or pyrogens?
No, USP <71> is intended to detect viable bacteria and fungi. Additional tests are required for endotoxins and viral contamination
2. How long does USP <71> sterility testing take?
USP <71> usually takes 3-4 weeks to complete
3. What is the preferred method of sterility testing?
Membrane filtration is generally preferred for sterility testing for filterable pharmaceutical products .
4. What happens if microbial growth is observed?
Microbial growth presence usually indicates a failure of the product under USP <71> test method
5. Is USP <71> harmonized internationally?
Yes, USP <71> is harmonized with EP 2.6.1 and JP 4.06
6. What is the difference between USP <71> and USP <61>?
USP <71> is used to confirm that a sterile product is free from viable microorganisms and provides a Pass/Fail result. USP <61> measures the microbial load in non-sterile products by determining the number of microorganisms present.
7. What is the difference between membrane filtration and direct inoculation?
Membrane filtration is generally preferred for filterable products, whereas direct inoculation is used for products that cannot be easily filtered.
8. Does passing USP <71> guarantee sterility?
No, It indicates absence of detectable contamination only. Additional procedures and tests can be done to confirm sterility
9. Why is incubation performed for 14 days?
14 day incubation period allows slow-growing organisms sufficient time to develop
10. What microorganisms are used during validation?
Standard bacterial and fungal strains are Staphylococcus aureus, Pseudomonas aeruginosa, Candida albicans
11. Can antimicrobial products interfere with testing?
Yes, antimicrobial products may inhibit microbial recovery if not properly neutralized
